Endothelin Receptor Antagonists (ETRA)
Customize your policy alerts
Sign up for Arizona Complete Health Policy AZ.CP.PHAR.1012 alerts
Get alerted when Policy AZ.CP.PHAR.1012 changes without checking for updates manually.
Monitor payer policy activity
Prior authorization and medical-necessity requirements for ambrisentan (Letairis), bosentan (Tracleer), and macitentan (Opsumit) for Arizona Medicaid members, including initial and continued therapy, preferred-product requirements, step therapy, documentation, and non-covered indications.
A maximum quantity per day was added.
Wording was added to specify that the criteria also apply to Care1st.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.